M: Defining patient needs and delivering evidence-based palliative and end-of-life care for non-malignant disease, through services that can be delivered in developed and low-income countries
Submitting Institution
University of EdinburghUnit of Assessment
Clinical MedicineSummary Impact Type
HealthResearch Subject Area(s)
Medical and Health Sciences: Nursing, Public Health and Health Services
Summary of the impact
Impact: Health and welfare; evidence-based palliative care for
patients with non-malignant disease beyond cancer patients and in
low-income countries; influencing policy; public engagement.
Significance: Care quality-standard changes and targeted
interventions: for example, up to 50% fewer unplanned hospital admissions
from nursing homes. Palliative care service development/redesign
internationally; clinical tools deployed internationally.
Beneficiaries: Patients and their families/carers; NHS and
healthcare providers; policymakers including UK and international
governments; medical charities.
Attribution: The work was performed by an international team led
by S. Murray at UoE.
Reach: International; policy changes and new guidelines/service
structures in 11 countries (UK, Europe, N. America, Asia, sub-Saharan
Africa); applicable to all those at end of life.
Underpinning research
Using a qualitative, rigorous serial interview technique, Professor Scott
Murray (St Columba's Hospice Professor of Primary Palliative Care, UoE,
1990-present), with Dr Kirsty Boyd (Honorary Clinical Senior Lecturer,
UoE, 2000-present) and Dr Marilyn Kendall (Senior Research Fellow, UoE,
1999-present), were the first to establish the needs of patients
terminally ill with non-malignant disease, highlighting the health
inequalities affecting this group [3.1].
Prior to 2000, palliative care was largely limited to cancer patients in
the last month of life in hospices in developed countries. Since 2001,
Murray has created an internationally leading team to establish the
evidence base to inform palliative care interventions and pathways for
non-malignant disease. The breadth of this multi-disciplinary research
group has enabled construction of a wide paradigm of palliative care.
International collaborative research evolving from this activity has led
to developments in Europe, America, Africa and Australasia.
Supported by major awards (e.g., £467K from the National Institute for
Health Research), Murray generated a compelling dataset on which
innovations to redesign palliative care services could be based. Murray,
Boyd and Kendall designed multi-perspective, serial, in-depth interviews
and deployed them with patients with various progressive illnesses (lung
cancer, bowel cancer, glioma, heart failure, chronic obstructive pulmonary
disease (COPD), liver failure, frailty) and their carers. This enabled the
team to describe and explore dying experiences, and identify and map
typical patterns of physical, social, psychological and spiritual distress
at the end of life [3.1, 3.2].
The work established compelling evidence that palliative care should be
implemented:
-
To all patients with progressive life-threatening illness,
not just cancer patients as currently predominates [3.3]. Indeed, there
has been a 200% increase in non-cancer palliative care patients in the
UK since 2008. Murray established that patients with heart failure and
COPD have a similar symptom burden and indeed have this for longer than
do patients with cancer [3.4].
-
At diagnosis, not just in the terminal stages. By
clearly demonstrating that patients may have greater distress at, or
even before, formal diagnosis of cancer than in the terminal stage, and
by mapping all dimensions of health (physical, social, psychological and
spiritual) in individuals with life-threatening illness and their
carers; the work established the importance and interconnectedness of
these factors [3.5].
-
In low-income and transitional economies. The
team showed that palliative care can function in healthcare
resource-poor environments [3.6].
References to the research
3.1 Kendall M, Murray S, Carduff A, et al. Use of multiperspective
qualitative interviews to understand patients' and carers' beliefs,
experiences, and needs. BMJ. 2009;339:b4122. DOI: 10.1136/bmj.b4122.
3.2 Murray S, Sheikh A. Serial interviews for patients with progressive
diseases. Lancet. 2006;368:901-2. DOI: 10.1016/S0140-6736(06)69350-1.
3.3 Murray S, Kendall M, Boyd K, Sheikh A. Illness trajectories and
palliative care. BMJ. 2005;330:1007-11. DOI: 10.1136/bmj.330.7498.1007.
3.4 Murray S, Boyd K, Kendall M, Worth A, Benton T, Clausen H. Dying of
lung cancer or cardiac failure: prospective qualitative interview study of
patients and their carers in the community. BMJ. 2002;325:929. DOI:
10.1136/bmj.325.7370.929.
3.5 Murray S, Kendall M, Boyd K, Grant L, Highet G, Sheikh A. Archetypal
trajectories of social, psychological, and spiritual wellbeing and
distress in family care givers of patients with lung cancer: secondary
analysis of serial qualitative interviews. BMJ. 2010;340:c2581. DOI:
10.1136/bmj.c2581.
3.6 Murray S, Grant E, Grant A, Kendall M. Dying from cancer in developed
and developing countries: lessons from two qualitative interview studies
of patients and their carers. BMJ. 2003;326:368. DOI:
10.1136/bmj.326.7385.368.
Details of the impact
Pathways to impact
Because of the "orphan" nature of non-cancer palliative care at the
outset of the work, the team engaged in an important drive to establish
the importance of this service and its development with professional
groups and healthcare students. To assist in this, Murray and colleagues
founded the International Primary Palliative Care Network in 2007. This
global network (committee members from UK, Australia, Canada, South
Africa, Belgium) leads its field in research, advocacy and service
innovation. It helps researchers from all continents collaborate and
advocate for palliative care in the community.
Impact on clinical practice and education
Murray's team developed the Supportive & Palliative Care Indicators
Tool (SPICT) to identify for palliative care more people dying with
conditions such as COPD and dementia [5.1]. In 2009, they introduced
routine advance care planning in all nursing homes in Midlothian,
Scotland, decreasing hospital admissions by 50%, and greatly improving the
overall quality of care as evaluated by relatives. Both of these
interventions are now being rolled out throughout the UK; the latter won a
Scottish Award for Excellence in Dementia Care and has prevented thousands
of hospital admissions and deaths, with considerable economic benefits
[5.2]. Internationally, the SPICT has been adopted in the UK, Spain,
Holland, Ireland and Uganda.
All UK hospices now have community care teams supporting patients with
non-malignant diseases. Non-cancer palliative care rose from 6% of UK
services in 2000 to 18% in 2012 (National Council for Palliative Care
[5.3]). The research has also informed quality improvement standards for
heart failure in UK and Europe [5.4].
Regarding educational practice, in 2008, the team won the BMJ's "Making a
Difference Campaign", so that until 2011, the BMJ prioritised publications
about non-cancer palliative care. Moreover, this opportunity was used to
advocate successfully for a new journal, BMJ Supportive & Palliative
Care, launched in 2011. Illustrations of the conceptual framework for
service are now incorporated in major undergraduate and postgraduate
medical texts [e.g., 5.5].
Impact on public policy
Through the Palliative Care Network and other channels, such as the
independent think-tank Demos, which cited the work in 2010 [5.6], Murray
and colleagues have stimulated governmental and public debate about
demographic and end-of-life challenges. The work has directly influenced
both UK Government policy and previously cancer-only-funding charities,
such as Marie Curie Cancer Care, so that they are both now investing twice
as much in palliative care for non-cancer patients than they were a decade
ago.
UK, Irish and Singaporean government policies reference the work
[5.7-5.9, respectively], calling for a re-design of services to better
meet diverse needs. In 2013, Murray, as an executive member of the
International Association of Hospice and Palliative Care, co-authored a
successful submission to the World Health Organization to list palliative
care medications in a separate section from oncology, and for morphine to
be listed as an essential medicine for palliative care for the first time.
Impact on society
Murray became a founder member of a national group to encourage a public
discourse about death and dying, and mobilise communities and individuals
to be involved in preventing and minimising distress at the end of life.
The website of this group had 1908 unique hits during a recent "death
awareness" week [5.10]. Similar public involvement strategies are
increasingly being integrated in other national end-of-life strategies
[e.g., 5.9].
Impact on international development
In 2011, the team was instrumental in founding an African Palliative Care
Research Network, which currently supports the first African-based BSc and
MSc in palliative care. Furthermore, the group, with Edinburgh University
Global Health Academy, was awarded a £1.5M Department for International
Development grant to integrate palliative care into the health systems of
Rwanda, Kenya, Uganda and Zambia. The team has helped develop the first
patient pathway for palliative care from a tertiary hospital down to
district and health centre levels in Africa. The Palliative Care Unit at
Makerere University, Uganda, led by Leng (Honorary Research Fellow, UoE),
trials many innovations. African Ministry of Health personnel have
attended training in Edinburgh, and the team has advised the Zambian
Ministry of Health on cervical cancer care.
Sources to corroborate the impact
5.1 Boyd K, Murray S. Recognising and managing key transitions in end of
life care. BMJ 2010;341:c4863. DOI: 10.1136/bmj.c4863.
5.2 Badger F,Clifford C, Hewison A, Thomas K. An evaluation of the
implementation of a programme to improve end-of-life care in nursing
homes. Palliat Med. 2009;23:502-11. DOI: 10.1177/0269216309105893.
5.3 National Council for Palliative Care (2013). National Survey of
patient activity data for specialist palliative care services.
http://www.ncpc.org.uk/sites/default/files/MDS%20Full%20Report%202012_1.pdf
[page 44.]
5.4 Jaarsma T, Beattie J, Ryder M, et al; Advanced Heart Failure Study
Group of the HFA of the ESC Palliative care in heart failure: a position
statement from the palliative care workshop of the Heart Failure
Association of the European Society of Cardiology. Eur J Heart Fail.
2009;11:433-43. DOI: 10.1093/eurjhf/hfp041.
5.5 Davidson's Principles & Practice of Medicine. 21st
Edition, London; Churchill Livingston [Available on request. See page
284].
5.6 Garber J, Leadbeater C. Dying for Change. London; DEMOS (2010).
http://www.demos.co.uk/publications/dyingforchange.
[Murray's work cited on p. 27 and 28.]
5.7 UK Department of Health (2008). End of life Care Strategy: promoting
high quality care for all adults at the end of life
http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_086277.
5.8 The Irish Hospice Foundation (2011). Primary Palliative Care in
Ireland: Identifying improvements in primary care to support the care of
those in their last year of life
http://www.lenus.ie/hse/bitstream/10147/192381/1/Primary%20Palliative%20Care%20in%20Ireland.pdf.
5.9 Singaporean guidelines. Duke Nus Graduate Medical School. Report on
the National Strategy for Palliative Care. Singapore (2011). http://www.dukenus.edu.sg/sites/default/files/Report_on_National_Strategy_for_Palliative_Care%2031Jan2012_0.pdf.
[Murray and team's work referenced on pages 14, 15 & 61.]
5.10 Scottish Partnership for Palliative Care. Good Life, Good Death,
Good Grief website.
http://www.goodlifedeathgrief.org.uk/content/about/.